SCHEMBL30030272

SCHEMBL30030272

N#Cc1ccc(-c2cccc(-c3cc(-c4ccc(Cl)cc4)nc(-c4ccccc4)n3)c2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 3/20 0.53
▸ ADORA2A P29274 1/20 0.50
▸ ADORA1 P30542 1/20 0.50
▸ CTRC Q99895 1/20 0.49
▸ MYC P01106 1/20 0.48
▸ SQOR Q9Y6N5 1/20 0.48
▸ GABRA1 P14867 1/20 0.48
▸ GABRG2 P18507 1/20 0.48
▸ GABRB3 P28472 1/20 0.48
▸ GABRA5 P31644 1/20 0.48
▸ GABRA3 P34903 1/20 0.48
▸ ABCB1 P08183 2/20 0.47
▸ MAPT P10636 4/20 0.47
▸ MEN1 O00255 4/20 0.47
▸ KMT2A Q03164 4/20 0.47
▸ LMNA P02545 4/20 0.47
▸ HPGD P15428 4/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ KDM4E B2RXH2 3/20 0.47
▸ GLA P06280 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24776412 1.00 ABCG2 (0.53) ABCG2ADORA2AADORA1CTRCMYC
SCHEMBL18010659 0.93 ABCG2 (0.59) ABCG2ADORA2AADORA1CTRCMYC
SCHEMBL23383792 0.92 ABCG2 (0.58) ABCG2MYCGABRA1GABRG2GABRB3
SCHEMBL23383682 0.90 ABCG2 (0.57) ABCG2MYCGABRA1GABRG2GABRB3
SCHEMBL24782248 0.90 ABCG2 (0.50) ABCG2ADORA2AADORA1CTRCMYC
SCHEMBL30832032 0.90 ABCG2 (0.50) ABCG2ADORA2AADORA1CTRCMYC
SCHEMBL23383817 0.90 ABCG2 (0.57) ABCG2MYCGABRA1GABRG2GABRB3
SCHEMBL23383798 0.90 ABCG2 (0.57) ABCG2MYCGABRA1GABRG2GABRB3
SCHEMBL23383812 0.89 ABCG2 (0.58) ABCG2MYCGABRA1GABRG2GABRB3
SCHEMBL23383810 0.89 ABCG2 (0.58) ABCG2MYCGABRA1GABRG2GABRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240268223-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2024-08-08 — — US disclosed
CN-117693499-A Compound, material for organic electroluminescent element, and electronic device 出光兴产株式会社 2024-03-12 — — CN disclosed
WO-2022264826-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE 出光興産株式会社 2022-12-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240268223-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, OR10J3, TMEM109 ABCG2 3457/4885ADORA2A 4341/4885ADORA1 3599/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback